Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy.
about
Ending the HIV/AIDS epidemic in low- and middle-income countries by 2030: is it possible?Long-acting combination anti-HIV drug suspension enhances and sustains higher drug levels in lymph node cells than in blood cells and plasma.Long acting systemic HIV pre-exposure prophylaxis: an examination of the field.The Application of Humanized Mouse Models for the Study of Human Exclusive Viruses.Nanomedicine formulations for the delivery of antiviral drugs: a promising solution for the treatment of viral infections.Advancements in nano-enabled therapeutics for neuroHIV management.Advances in nanomedicine drug delivery applications for HIV therapy.Increasing Distribution of Drugs Released from In Situ Forming PLGA Implants Using Therapeutic Ultrasound.Translation of combination nanodrugs into nanomedicines: lessons learned and future outlook.Long-acting injectable atovaquone nanomedicines for malaria prophylaxis.Long-acting formulations for the treatment of latent tuberculous infection: opportunities and challenges.Lack of interaction of lopinavir solid drug nanoparticles with cells of the immune system.Optimizing the preparation and stability of decorated antiretroviral drug nanocrystals.
P2860
Q28073723-97330F2D-1401-48ED-A083-1E598706B8C3Q37693640-F05E19E2-5DD3-47B8-9EEC-F925D16D5B2DQ39371494-FD1627B8-87DC-45F5-9A7A-F4638D7AEB84Q39545359-CD9C3759-0E71-42AA-A8C8-7F17FB54C4D3Q40105941-74B01C2E-B321-4147-9433-B72DB89D6B3AQ40542601-3D3A5525-1831-4F19-A59E-1216900BA408Q47112878-3CCCB8ED-F221-427E-AC2C-4F82249D0C1FQ47656366-E046F9F6-6DF0-40B3-8F4A-13350523711FQ47760026-E42009CF-21A9-4AC6-97F5-F7AF2F620496Q48022850-BF361256-EB52-435D-99FD-B97B623BA19EQ52673482-5338DAAC-1DA3-43F9-A6EF-3CAA71958930Q53555823-10A34324-83F4-4A57-8C33-968343976479Q54253541-393BF491-8E3A-418E-86A9-12E2B91B4C1A
P2860
Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Strengths, weaknesses, opportu ...... r applications in HIV therapy.
@en
type
label
Strengths, weaknesses, opportu ...... r applications in HIV therapy.
@en
prefLabel
Strengths, weaknesses, opportu ...... r applications in HIV therapy.
@en
P2860
P1476
Strengths, weaknesses, opportu ...... r applications in HIV therapy.
@en
P2093
Steve Rannard
P2860
P304
P356
10.1016/J.ADDR.2016.02.003
P407
P577
2016-02-22T00:00:00Z